Impact ledger
Neurogene Inc. (NGNE)
3 events mapped to this ticker since 2026-06-29.
Assumption changes
| Date | Assumption | Direction | Magnitude | Conf. |
|---|---|---|---|---|
| 2026-07-02 | multiple | Bearish | — | 0.70 |
| 2026-07-02 | share_count | Bullish | — | 0.70 |
Event impact log
| Date | Event | Channel | Direction | Horizon | Impact |
|---|---|---|---|---|---|
| 2026-07-02 | Event | Dilution from new share issuance; potential downward pressure on stock price due to increased supply and uncertainty regarding use of proceeds. | Bearish | 1-3m | 0.80 |
| 2026-06-29 | Event | Direct positive clinical trial results for lead gene therapy candidate, increasing probability of regulatory approval and commercialization. | Bullish | 1-3m | 0.90 |
| 2026-06-29 | Event | Direct impact on product pipeline valuation and investor sentiment due to positive clinical trial data for a lead candidate. | Bullish | 1-3m | 0.90 |
This ledger is regenerated from Market Ontology's public event pipeline. For live alerts on new assumption changes for NGNE, start a trial or view the NGNE entity page.